Matrix metalloproteinases like MMP-13 cleave and remodel the extracellular matrix and thereby play a crucial role in tumor progression in vivo. Using a highly selective inhibitor to block MMP-13 protein activity, we demonstrate a striking inhibitory effect on invasive tumor growth and vascularization in murine skin squamous cell carcinoma (SCC). Therapy outcome critically depends on animal age in C57Bl/6 mice and was successful in old female but not in young female mice. Treatment success was recovered by ovariectomy in young and abolished by 17ß-estradiol supplementation in old mice, suggesting a hormone dependent inhibitor effect. Responsiveness of the tumorigenic keratinocytes BDVII and fibroblasts to 17ß-estradiol was confirmed in vitro, where MMP-13 inhibitor treatment led to a reduction of cell invasion and vascular endothelial growth factor (VEGF) release. This correlated well with a less invasive and vascularized tumor in treated mice in vivo. 17ß-estradiol supplementation also reduced invasion and VEGF release in vitro with no additional reduction on MMP-13 inhibitor treatment. This suggests that low 17ß-estradiol levels in old mice in vivo lead to enhanced MMP-13 levels and VEGF release, allowing a more effective inhibitor treatment compared to young mice. In our study, we present a strong link between lower estrogen levels in old female mice, an elevated MMP-13 level, which results in a more effective MMP-13 inhibitor treatment in fibroblasts and SCC cells in vitro and in vivo.Matrix metalloproteinases (MMPs) are a family of structurally related zinc dependent endopeptidases 1 that contribute to physiological remodeling of the extracellular matrix (ECM) in embryonic development, wound healing and angiogenesis.
2Beyond that, MMPs are involved in pathological conditions, including chronic wounds, rheumatoid arthritis and cancer. In cancer, they show host protective functions like cleavage and inactivation of chemokines that mediate organ-specific metastasis 3,4 and are involved in enhancing bioavailability and activation of cytokines and chemokines. This includes the release of vascular endothelial growth factor (VEGF) from the matrix, leading to an induction of angiogenesis in vivo.5,6 Among the MMPs, collagenases (MMP-1, MMP-8 and MMP-13) play an important role in tumor invasion and metastasis due to their ability to degrade native fibrillar collagen. 7 Human collagenase 1 (hMMP-1) is expressed by keratinocytes, fibroblasts, endothelial cells and others under physiological conditions. 1 In numerous tumors like breast, gastric and oesophageal carcinoma, it is associated with tumor progression or poor clinical outcome and serves as tumor marker in vivo.8-11 Expression of human collagenase-3 (hMMP-13) is associated with invasion and metastasis in a variety of malignant tumors [breast, squamous cell carcinomas (SCCs), HNSCCs and melanomas] 12-15 where it is found in tumor cells, but also in stromal cells. [16][17][18] Tumor progression is mediated by a crosstalk between tumor and stromal cells like fibr...